COMMUNIQUÉS West-GlobeNewswire

Valneva to Report First Quarter 2026 Consolidated Financial Results on May 13, 2026
06/05/2026
Lyon (France), May 6 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it will report its first quarter 2026 financial results on Wednesday, May 13, 2026. The [...]
Valneva publiera ses résultats financiers consolidés du premier trimestre le 13 mai 2026
06/05/2026
Lyon (France), le 6 mai 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui qu’elle publiera ses résultats financiers du premier trimestre le mercredi 13 [...]
Hermest Hair Clinic Announces Leadership of Dr. Nesim Tugen as Medical Director Enhancing Clinical Excellence
06/05/2026
Istanbul, Turkey, May 06, 2026 (GLOBE NEWSWIRE) -- Hermest Hair Transplant Clinic has announced the continued leadership of Dr. Nesim Tugen as Medical Director, reinforcing clinical oversight and advancing treatment [...]
Avacta presents new comparisons of pre|CISION® payload release vs approved ADCs and AVA6207 dual payload delivery at Science Day 2026
06/05/2026
LONDON and PHILADELPHIA, May 06, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, "the Company", "Avacta"), a clinical stage biopharmaceutical company developing pre|CISION ® , a tumor-activated oncology [...]
Immutrin appoints leading cardiovascular drug development expert Dr. Robert Blaustein as Chief Medical Officer and establishes US subsidiary
06/05/2026
Former Edgewise and Merck leader brings more than 15 years’ experience to guide Immutrin’s clinical strategy as the Company advances towards first-in-human studies Cambridge, UK, 6 th May 2026 Immutrin Ltd, (“Immutrin” [...]
Novo Nordisk's adjusted operating profit reached DKK 32,858 million in Q1 2026
06/05/2026
Bagsværd, Denmark, 6 May 2026 - Financial report for the period 1 January 2026 to 31 March 2026 Financial performance Q1 2026 reported sales increased by 32% at CER, positively impacted by a provision reversal related [...]
IBA Introduces myQA StarTrack³ for Fast, High Resolution Linac QA with a Single Detector Setup
06/05/2026
One setup. One detector. Complete beam insight. Louvain-la-Neuve, Belgium, 06 May 2026 – (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and a global provider of dosimetry and [...]
IBA lance myQA StarTrack³ une solution haute résolution pour une assurance qualité des accélérateurs linéaires rapide et précise, avec une seule mise en place du détecteur
06/05/2026
Une installation. Un détecteur. Une caractérisation complète du faisceau. Louvain-la-Neuve, Belgique, 6 mai 2026 – IBA (Ion Beam Applications S.A., EURONEXT), leader mondial de la technologie d'accélérateurs de [...]
Philips delivers strong order intake, comparable sales growth and margin expansion in Q1; 2026 outlook reiterated
06/05/2026
May 6, 2026 Q1 2026 Group performance Comparable order intake growth 6% Group sales of EUR 3.9 billion, reflecting 4% increase in comparable sales Income from operations increased to EUR 241 million Adjusted EBITA [...]
Avalo Therapeutics Announces Pricing of $375 Million Public Offering
06/05/2026
WAYNE, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ: AVTX) (“Avalo”), a clinical-stage biotechnology company fully dedicated to developing IL-1β based treatments for immune-mediated [...]
Rapid Nutrition Enhances Investor Access with Agentic AI driven On-Demand Communication Platform
06/05/2026
LONDON, May 05, 2026 (GLOBE NEWSWIRE) -- Rapid Nutrition PLC (Euronext Growth: ALRPD ), a global HealthTech company advancing wellness through evidence-based, personalized nutrition solutions, today announced the [...]
WriteUpp Introduces Embedded AI Medical Scribe With SOAP, DAP and BIRP Note Generation at CA$40 Per User
06/05/2026
The new per-user add-on brings structured AI clinical documentation into Notes, Documents, and Assessments, giving Canadian therapists, physiotherapists, and allied health professionals a flexible and compliant way to [...]
LBL-047 Prioritized for Clinical Development in Sjögren's Disease, Systemic Lupus Erythematosus, and Dermatomyositis
06/05/2026
NANJING, China, May 05, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs"; Stock Code: 9887.HK) today announced that its partner, Dianthus Therapeutics, Inc. (“Dianthus”; NASDAQ: DNTH), has [...]
HealthEquity Announces First Quarter Earnings Release Date and Investor Conference Schedule
05/05/2026
DRAPER, Utah, May 05, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health savings account (HSA) custodian by account volume and a leader in [...]
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/05/2026
BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced that [...]
Ligand to Participate in May Investor Conferences
05/05/2026
JUPITER, Fla., May 05, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its senior management team will participate in the following upcoming investor conferences: H.C. [...]
Avalyn to Present Patient-Centered Research on AP01 Delivery and Supportive Care Experiences at American Thoracic Society 2026 International Conference
05/05/2026
BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (Nasdaq: AVLN), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory [...]
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/05/2026
BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the grant of [...]
Carlsmed® Reports First Quarter 2026 Financial Results
05/05/2026
First quarter 2026 revenue of $16.1 million, representing 58% growth year-over-year Full year 2026 revenue guidance raised to $72 million to $77 million CARLSBAD, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc [...]

Pages